Literature DB >> 30484509

Reintervention in Artificial Cardiac Pacing Systems.

Silas Dos Santos Galvão Filho1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30484509      PMCID: PMC6248248          DOI: 10.5935/abc.20180222

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
Reintervention in artificial cardiac pacing systems that involves lead approach, either for the implantation of a new lead and/or the removal of an old one, is most frequently a difficult procedure, with a high probability of complications. Since the transvenous endocardial route started being used by artificial cardiac pacing systems, lead cables have shown to be more vulnerable to complications;[1] however, when it comes to reintervention, the complications are much more frequent. The significant prevalence of venous obstruction[2] and the consequent difficulty in obtaining a new venous access, the complexity of percutaneous extraction of old lead cables,[3] in addition to the higher prevalence of surgical infections,[4] constitute some of the complications that determine the greater complexity of reinterventions. The study “Usefulness of preoperative venography in patients with cardiac implantable electronic devices submitted to lead replacement or device upgrade procedures”,[5] calls attention to this ever-growing problem,[6] as the implantable electronic cardiac devices use more lead cables and increase the patients’ life expectancy, in addition to emphasizing the importance of a previous venography to program the approach strategy. In the present study, approximately 1/4 of the patients submitted to reintervention had severe venous obstructions or occlusions. In such cases, when a new lead cable is required, the extraction of old ones may be absolutely necessary to attain access. The venous system exploration through the venography can be performed intraoperatively; however, prior knowledge of possible obstructions allows better programming of the surgical procedure, with a previous request of special materials, such as mechanical or laser-energized sheath systems for lead cable extraction, which should always be available in these cases. Moreover, considering the cost of these special materials, it is very important in the real world and in our country to have prior authorization from the health care providers to use them, determining cost predictability and minimizing problems when charging for the procedure. The agreement between the programmed and the actual surgical procedure, which occurred in the study in 99% of the cases, strongly reinforced the importance of performing a prior venography when scheduling reintervention procedures. The lack of knowledge of venous obstructions at the reinterventions leads to the unavailability of lead extraction systems during the procedure, and in those cases requiring the implantation of new lead(s) and in which access cannot be attained, implantation of a contralateral artificial cardiac pacing system while abandoning the old lead cables may be the only option. However, the increase in surgical time, which can result in a higher risk of infection, as well as the increased number of implanted leads, are considerable drawbacks of this approach. Advances in technology with the development of leadless pacemaker systems will, in the future, address problems with transvenous leads. Nevertheless, the current state of this technology[7],[8] with the use of single-chamber devices, is still not able in most cases, to dispense with traditional dual-chamber artificial heart pacing systems with leads, suggesting we will be facing such situations for a long time yet. As they constitute one of the most difficult and delicate surgical procedures in the area of artificial heart stimulation, re-interventions in lead cables must be very well programmed, in addition to requiring a level of high expertise by the surgeon/rhythmologist. In this sense, performing a venography prior to the procedure is very important, as it was well demonstrated by this article.
  7 in total

1.  A Leadless Intracardiac Transcatheter Pacing System.

Authors:  Dwight Reynolds; Gabor Z Duray; Razali Omar; Kyoko Soejima; Petr Neuzil; Shu Zhang; Calambur Narasimhan; Clemens Steinwender; Josep Brugada; Michael Lloyd; Paul R Roberts; Venkata Sagi; John Hummel; Maria Grazia Bongiorni; Reinoud E Knops; Christopher R Ellis; Charles C Gornick; Matthew A Bernabei; Verla Laager; Kurt Stromberg; Eric R Williams; J Harrison Hudnall; Philippe Ritter
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

2.  Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.

Authors:  Vivek Y Reddy; Derek V Exner; Daniel J Cantillon; Rahul Doshi; T Jared Bunch; Gery F Tomassoni; Paul A Friedman; N A Mark Estes; John Ip; Imran Niazi; Kenneth Plunkitt; Rajesh Banker; James Porterfield; James E Ip; Srinivas R Dukkipati
Journal:  N Engl J Med       Date:  2015-08-30       Impact factor: 91.245

3.  Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights.

Authors:  Andrew Voigt; Alaa Shalaby; Samir Saba
Journal:  Pacing Clin Electrophysiol       Date:  2009-09-30       Impact factor: 1.976

4.  Transvenous lead extraction at the time of cardiac implantable electronic device upgrade: Complexity, safety, and outcomes.

Authors:  Amr F Barakat; Oussama M Wazni; Khaldoun Tarakji; Walid I Saliba; Nayef Nimri; John Rickard; Michael Brunner; Mandeep Bhargava; Mohamed Kanj; Bryan Baranowski; David O Martin; Daniel Cantillon; Thomas Callahan; Thomas Dresing; Mark Niebauer; Mina Chung; Bruce D Lindsay; Bruce Wilkoff; Ayman A Hussein
Journal:  Heart Rhythm       Date:  2017-08-23       Impact factor: 6.343

Review 5.  Pacemaker leads: performance and progress.

Authors:  W G de Voogt
Journal:  Am J Cardiol       Date:  1999-03-11       Impact factor: 2.778

6.  Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures.

Authors:  Arnold J Greenspon; Jasmine D Patel; Edmund Lau; Jorge A Ochoa; Daniel R Frisch; Reginald T Ho; Behzad B Pavri; Steven M Kurtz
Journal:  J Am Coll Cardiol       Date:  2012-09-19       Impact factor: 24.094

7.  Prevalence and predictor factors of severe venous obstruction after cardiovascular electronic device implantation.

Authors:  Massimo Santini; Stefania Angela Di Fusco; Andrea Santini; Barbara Magris; Carlo Pignalberi; Stefano Aquilani; Furio Colivicchi; Alessio Gargaro; Renato Pietro Ricci
Journal:  Europace       Date:  2015-12-24       Impact factor: 5.214

  7 in total
  2 in total

1.  Effectiveness and Safety of Transvenous Removal of Cardiac Pacing and Implantable Cardioverter-defibrillator Leads in the Real Clinical Scenario.

Authors:  Roberto Costa; Katia Regina da Silva; Elizabeth Sartori Crevelari; Wagner Tadeu Jurevicius Nascimento; Marcia Mitie Nagumo; Martino Martinelli Filho; Fabio Biscegli Jatene
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

2.  Infections of Cardiac Implantable Electronic Devices - A Growing, Worrying Reality.

Authors:  Eduardo Arrais Rocha; João Lins de Araújo Neto; Ricardo Pereira Silva
Journal:  Arq Bras Cardiol       Date:  2021-06       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.